Friedreich's ataxia (FA) is a recessive, predominantly neurodegenerative disorder caused in most cases by mutations in the first intron of the frataxin (FXN) gene. This mutation drives the expansion of a homozygous GAA repeat that results in decreased levels of FXN transcription and frataxin protein. Frataxin (Fxn) is a ubiquitous mitochondrial protein involved in iron-sulfur cluster biogenesis, and a decrease in the levels of this protein is responsible for the symptoms observed in the disease. Although the pathological manifestations of FA are mainly observed in neurons of both the central and peripheral nervous system, it is not clear if changes in nonneuronal cells may also contribute to the pathogenesis of FA, as recently suggested for other neurodegenerative disorders. Therefore, the aims of this study were to generate and characterize a cell model of Fxn deficiency in human astrocytes (HAs) and to evaluate the possible involvement of non-cell autonomous processes in FA. To knockdown frataxin in vitro, we transduced HAs with a specific shRNA lentivirus (shRNA37), which produced a decrease in both frataxin mRNA and protein expression, along with mitochondrial superoxide production, and signs of p53-mediated cell cycle arrest and apoptotic cell death. To test for non-cell autonomous interactions we cultured wild-type mouse neurons in the presence of frataxin-deficient astrocyte conditioned medium, which provoked a delay in the maturation of these neurons, a decrease in neurite length and enhanced cell death. Our findings confirm a detrimental effect of frataxin silencing, not only for astrocytes, but also for neuron-glia interactions, underlining the need to take into account the role of non-cell autonomous processes in FA.
Introduction
Friedreich's ataxia (FA) is a hereditary disorder caused in most cases by the expansion of GAA repeats in the first intron of the frataxin (FXN) gene, which dampens the expression of frataxin (Fxn), a protein involved in the biogenesis of iron-sulfur clusters and the regulation of oxidative stress (Campuzano et al., 1996; Campuzano et al., 1997; Pastore and Puccio, 2013) . FA is characterized by progressive neurodegeneration that mainly affects the dorsal root ganglia, the corticospinal and spinocerebellar tracts of the spinal cord, and the deep cerebellar nuclei (Delatycki and Corben, 2012; Koeppen and Mazurkiewicz, 2013) . Until recently, neurodegenerative diseases have been regarded as exclusively neuronal disorders and the contribution of non-neuronal cells to FA has been largely ignored. However, there is now considerable evidence that the selective death of certain types of neurons is not only due to intrinsic changes within the vulnerable neurons but also, to additional changes within neighboring non-neuronal glial cells (Verkhratsky et al., 2012) . Indeed, non-cell autonomous mechanisms mediated by glial dysfunction appear to contribute to the vulnerability of neurons in many neurodegenerative diseases (Liu et al., 2005; Ilieva et al., 2009; Lu et al., 2009; Rodriguez and Verkhratsky, 2011; Tao et al., 2011; Di Malta et al., 2012; Garden and La Spada, 2012; Meyer et al., 2014) . In the case of FA, specific silencing of Fxn in glial cells triggers a phenotype in Drosophila similar to that observed after ubiquitous Fxn reduction, characterized by altered lipid metabolism in glial cells, degeneration of neurons, severely impaired locomotor activity and reduced lifespan (Navarro et al., 2010). Thus, it seems plausible that non-cell autonomous processes might contribute to neurodegeneration in FA.
Astrocytes are the most abundant glial cell type in the central nervous system (CNS), and fulfill a wide variety of complex and essential functions responsible for maintaining brain homeostasis (Barres, 2008; Belanger et al., 2011) , such as: controlling fluid movement between the intracellular and extracellular space; protecting neurons against oxidative stress; regulating energy metabolism and blood flow; and modulating neuronal activity through the expression of cytokines, growth factors and transporters (Sofroniew and Vinters, 2010; Allaman et al., 2011 
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